146 related articles for article (PubMed ID: 17295656)
1. Impairments of the biological properties of serum albumin in patients on haemodialysis.
Lim PS; Cheng YM; Yang SM
Nephrology (Carlton); 2007 Feb; 12(1):18-24. PubMed ID: 17295656
[TBL] [Abstract][Full Text] [Related]
2. The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst.
Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Otagiri M
Biochem Biophys Res Commun; 2005 Sep; 334(4):1322-8. PubMed ID: 16054887
[TBL] [Abstract][Full Text] [Related]
3. Investigation of albumin properties in patients with chronic renal failure.
Pieniazek A; Brzeszczynska J; Kruszynska I; Gwozdzinski K
Free Radic Res; 2009 Oct; 43(10):1008-18. PubMed ID: 19707919
[TBL] [Abstract][Full Text] [Related]
4. Structure and binding properties of serum albumin in uremic patients at different periods of hemodialysis.
Sarnatskaya VV; Ivanov AI; Nikolaev VG; Rotellar E; von Appen K; Haspar M; Maslenny VN; Klinkmann H
Artif Organs; 1998 Feb; 22(2):107-15. PubMed ID: 9491899
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte transmembrane electron transfer in haemodialysis patients.
Matteucci E; Cupisti A; Caprioli R; Battipaglia E; Favilla S; Rindi P; Barsotti G; Giampietro O
Nutr Metab Cardiovasc Dis; 2007 May; 17(4):288-93. PubMed ID: 17434051
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies.
Rasheed Z; Ali R
Life Sci; 2006 Nov; 79(24):2320-8. PubMed ID: 16945391
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species damaged human serum albumin in patients with hepatocellular carcinoma.
Rasheed Z; Ahmad R; Rasheed N; Ali R
J Exp Clin Cancer Res; 2007 Sep; 26(3):395-404. PubMed ID: 17987802
[TBL] [Abstract][Full Text] [Related]
8. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions.
Kawakami A; Kubota K; Yamada N; Tagami U; Takehana K; Sonaka I; Suzuki E; Hirayama K
FEBS J; 2006 Jul; 273(14):3346-57. PubMed ID: 16857017
[TBL] [Abstract][Full Text] [Related]
10. [Structure and function changes of oxidized human serum albumin: physiological significance of the biomarker and importance of sampling conditions for accurate measurement].
Yamada N; Nakayama A; Kubota K; Kawakami A; Suzuki E
Rinsho Byori; 2008 May; 56(5):409-15. PubMed ID: 18546891
[TBL] [Abstract][Full Text] [Related]
11. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
Undas A; Kolarz M; Kopeć G; Tracz W
Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
[TBL] [Abstract][Full Text] [Related]
12. Phospholipid hydroperoxide cysteine peroxidase activity of human serum albumin.
Hurst R; Bao Y; Ridley S; Williamson G
Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):723-8. PubMed ID: 10051445
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against N-homocysteinylated proteins in patients on long-term haemodialysis.
Undas A; Kolarz M; Kopec G; Glowacki R; Placzkiewicz-Jankowska E; Tracz W
Nephrol Dial Transplant; 2007 Jun; 22(6):1685-9. PubMed ID: 17317712
[TBL] [Abstract][Full Text] [Related]
15. Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin.
Faure P; Wiernsperger N; Polge C; Favier A; Halimi S
Clin Sci (Lond); 2008 Feb; 114(3):251-6. PubMed ID: 17922677
[TBL] [Abstract][Full Text] [Related]
16. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
[TBL] [Abstract][Full Text] [Related]
17. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
[TBL] [Abstract][Full Text] [Related]
18. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
19. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
[TBL] [Abstract][Full Text] [Related]
20. Human serum albumin cysteinylation is increased in end stage renal disease patients and reduced by hemodialysis: mass spectrometry studies.
Regazzoni L; Del Vecchio L; Altomare A; Yeum KJ; Cusi D; Locatelli F; Carini M; Aldini G
Free Radic Res; 2013 Mar; 47(3):172-80. PubMed ID: 23215783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
